The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast CancerInna M. Yasinska(Medway School of Pharmacy), Vadim V. Sumbayev(Medway School of Pharmacy)Frontiers in ImmunologyJuly 11, 201910.3389/fimmu.2019.01594Cited by 171SaveCiteExport RISWatch citationsRelated PapersDifferential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells|Oncotarget|2015|55High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression|OncoImmunology|2018|45Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells|Oncotarget|2016|18